Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Turecek

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Journal of Biochemical and Biophysical Methods|August 1, 1989
Quantitative determination of pectic substances as an example of a rhamnopolysaccharide assayP L Turecek, E Buxbaum, F Pittner
Comparative Medicine|July 14, 2000
Deoxyribonucleic acid preparation in polymerase chain reaction genotyping of transgenic miceK Zimmermann, H P Schwarz, P L Turecek
Acta Neuropathologica|April 20, 1999
Genotyping of the prion protein gene at codon 129K Zimmermann, P L Turecek, H P Schwarz
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 24, 1999
The determination of von Willebrand factor activity by collagen binding assayJ Siekmann, P L Turecek, H P Schwarz
Haemostasis|March 7, 2000
Determination of the prevalence of fibrinogen Banks peninsula mutation (gamma280Tyr-->Cys) by PCRK Zimmermann, P L Turecek, H P Schwarz
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 24, 2004
Thrombin generation assay and other universal tests for monitoring haemophilia therapyK Váradi, P L Turecek, H P Schwarz
Blood|July 6, 2000
In vivo inhibition of low density lipoprotein receptor-related protein improves survival of factor VIII in the absence of von Willebrand factorP L Turecek, H P Schwarz, B R Binder
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 24, 2004
FEIBA: mode of actionP L Turecek, K Váradi, H Gritsch, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Immunoadsorption for the treatment of a patient with severe thrombotic thrombocytopenic purpura resistant to plasma exchange: kinetics of an inhibitor of ADAMTS13P Knöbl, M Haas, K Laczika, et al.
Vox Sanguinis|August 25, 2001
Preparation and properties of an alpha-1-protease inhibitor concentrate with high specific activityE Mattes, H P Matthiessen, P L Turecek, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Journal of Biochemical and Biophysical Methods|August 1, 1989
Quantitative determination of pectic substances as an example of a rhamnopolysaccharide assayP L Turecek, E Buxbaum, F Pittner
Comparative Medicine|July 14, 2000
Deoxyribonucleic acid preparation in polymerase chain reaction genotyping of transgenic miceK Zimmermann, H P Schwarz, P L Turecek
Acta Neuropathologica|April 20, 1999
Genotyping of the prion protein gene at codon 129K Zimmermann, P L Turecek, H P Schwarz
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 24, 1999
The determination of von Willebrand factor activity by collagen binding assayJ Siekmann, P L Turecek, H P Schwarz
Haemostasis|March 7, 2000
Determination of the prevalence of fibrinogen Banks peninsula mutation (gamma280Tyr-->Cys) by PCRK Zimmermann, P L Turecek, H P Schwarz
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 24, 2004
Thrombin generation assay and other universal tests for monitoring haemophilia therapyK Váradi, P L Turecek, H P Schwarz
Blood|July 6, 2000
In vivo inhibition of low density lipoprotein receptor-related protein improves survival of factor VIII in the absence of von Willebrand factorP L Turecek, H P Schwarz, B R Binder
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 24, 2004
FEIBA: mode of actionP L Turecek, K Váradi, H Gritsch, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Immunoadsorption for the treatment of a patient with severe thrombotic thrombocytopenic purpura resistant to plasma exchange: kinetics of an inhibitor of ADAMTS13P Knöbl, M Haas, K Laczika, et al.
Vox Sanguinis|August 25, 2001
Preparation and properties of an alpha-1-protease inhibitor concentrate with high specific activityE Mattes, H P Matthiessen, P L Turecek, et al.
Pageof 6